🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The More Than GOLD Gala isn’t just another night out, it’s a movement to #BeatChildhoodCancer. September 5. #Tampa. Armature Works. One night to stand for every child, every family, every future we refuse to lose. Tickets + sponsorships now live at beatcc.org/gold

It's week 24/52 of Take Action Tuesday! This week, we’re inviting you to go beyond awareness and be part of our story at our gala this year. Ready to shine More than GOLD? Connect with us at beatcc.org/gold

Please join us in welcoming Dr. Josée Brossard and her team at Site 88 – CIUSSS de l'Estrie-CHUS in Sherbrooke, Quebec Canada! They are officially approved to enroll on BCC015 – A Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory #Neuroblastoma.

BIG NEWS: OUR MERCH STORE IS LIVE! Every shirt, hoodie, hat and accessory helps fund less toxic, precision treatments that target the cancer, not the child. Check out our brand-new online store here: beatcc.org/shop/

A little throwback fun from past Falmouth Road Races! Team #BeatCC still has a few spots left for the 2025 Falmouth Road Race! Want to join us and run with purpose? Learn more and register at beatcc.org/falmouth Let’s go the distance for every child, everywhere!

Today marks the final day of #NationalCancerSurvivorsMonth. At #BeatChildhoodCancer, every single day we fight for the kids still in treatment, the survivors navigating life beyond cancer, and the angels whose stories fuel our urgency!

It’s Week 25/52 of Take Action Tuesday and today marks the start of Sarcoma Awareness Month... a time to lift up the stories of children and families facing some of the rarest, most aggressive cancers, and to fuel the research that gives them hope. #SarcomaAwarenessMonth

Welcome Dr. William Ferguson and his team at Site 02 – St Louis University! They are officially approved to enroll on BCC021– A Phase I/II study of Silmitasertib (CX-4945) in combination with chemotherapy in children and young adults with relapsed refractory solid tumors.

It’s week 26/52 of #TakeActionTuesday! This week, meet Renee Tocci! Our Stewardship Manager and proud member of Team BeatCC at this year’s Falmouth Road Race, Inc. Want to make your miles count? Join Team BeatCC! Learn more: secure.qgiv.com/event/falmouth

Exciting news: DFMO is now approved in Switzerland! 🇨🇭 Read more: prnewswire.com/news-releases/… #BeatChildhoodCancer #DFMO #EveryChildEverywhere #ChildhoodCancer #ChildhoodCancerResearch

Please join us in welcoming Dr. William Ferguson and his team at Site 02 – St Louis University in St Louis, MO! They are officially approved to enroll on BCC022 – a Phase II Trial of Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma. #BeatChildhoodCancer